日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The COVID-19 Clinician Cohort (CoCCo) Study: Empirically Grounded Recommendations for Forward-Facing Psychological Care of Frontline Doctors

新冠肺炎临床医生队列（CoCCo）研究：基于实证的面向一线医生的心理健康关怀建议

期刊:International Journal of Environmental Research and Public Health
影响因子:
doi:10.3390/ijerph18189675
Daniels, Jo; Ingram, Jenny; Pease, Anna; Wainwright, Elaine; Beckett, Kate; Iyadurai, Lalitha; Harris, Sophie; Donnelly, Olivia; Roberts, Tom; Carlton, Edward
肺炎
新冠
微生物学
发表日期：2021
文献求助 收藏

Assessing the activity of cediranib, a VEGFR-2/3 tyrosine kinase inhibitor, against VEGFR-1 and members of the structurally related PDGFR family

评估西地尼布（一种 VEGFR-2/3 酪氨酸激酶抑制剂）对 VEGFR-1 和结构相关的 PDGFR 家族成员的活性

期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-10-0976
Sandra R Brave, Kirsty Ratcliffe, Zena Wilson, Neil H James, Sue Ashton, Anna Wainwright, Jane Kendrew, Philippa Dudley, Nicola Broadbent, Graham Sproat, Sian Taylor, Claire Barnes, Jeffrey C Silva, Charles L Farnsworth, Laurent Hennequin, Donald J Ogilvie, Juliane M Jürgensmeier, Masabumi Shibuya, 
EGF
EGFR
信号转导
VEGF
发表日期：2011
文献求助 收藏

Vandetanib inhibits both VEGFR-2 and EGFR signalling at clinically relevant drug levels in preclinical models of human cancer

凡德他尼在人类癌症临床前模型中以临床相关的药物水平抑制 VEGFR-2 和 EGFR 信号传导

期刊:International Journal of Oncology
影响因子:4.5
doi:10.3892/ijo.2011.1022
Sandra R Brave, Rajesh Odedra, Neil H James, Neil R Smith, Gayle B Marshall, Kerry L Acheson, Dawn Baker, Zoe Howard, Lynsay Jackson, Kirsty Ratcliffe, Anna Wainwright, Susan C Lovick, D Mark Hickinson, Robert W Wilkinson, Simon T Barry, Georgina Speake, Anderson J Ryan
信号转导
肿瘤
Human
发表日期：2011
文献求助 收藏